L.A. Applegate

Discipline

Histoire, Philosophie et Sociologie des sciences (3) Anthropologie biologique (2) Psychologie (1) Gestion et management (1) Anthropologie sociale et ethnologie (1)

Type de document

Articles (57) Recensions (8) Autres (1)

Co-auteur

Date

Source

Mot-clé

Treatment (23) Patients (23) Patients (23) Cells (22) Human beings (20) Cellular therapy (19) peau (18) Development (18) Skin (18) Manufactures (18) tissu (corporel) (17) Process (Law) (17) Therapeutics (15) Management (15) Care (14) thérapie (13) sécurité (13) gestion (13) Wounds and injuries (13) Wound healing (13) Management (13) temps (durée) (12) régénération (12) Regeneration (12) Time (12) Days (12) Properties (12) Tissue engineering (12) Utilization (12) Swiss (11)

Documents écrit par L.A. Applegate (57) | parle de L.A. Applegate (0)

Comprehensive Evaluation of Injectability Attributes in OxiFree™ Dermal Fillers: MaiLi® Product Variants and Clinical Case Reports.
P. Micheels et al. (19 avr. 2024)
Mechanistic Insights into the Multiple Functions of Niacinamide: Therapeutic Implications and Cosmeceutical Applications in Functional Skincare Products.
C. Marques et al. (30 mars 2024)
Streamlined, single-step non-viral CRISPR-Cas9 knockout strategy enhances gene editing efficiency in primary human chondrocyte populations.
S. Ponta et al. (11 mars 2024)
A New Ex Vivo Human Skin Burn Model.
A. Labouchère et al. (4 mars 2024)
Ex Vivo Functional Benchmarking of Hyaluronan-Based Osteoarthritis Viscosupplement Products: Comprehensive Assessment of Rheological, Lubricative, Adhesive, and Stability Attributes.
A. Porcello et al. (9 oct. 2023)
Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification.
V. Philippe et al. (16 sept. 2023)
Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care.
X. Chen et al. (16 sept. 2023)
Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes: Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine.
A. Jeannerat et al. (3 juil. 2023)
Industrial Biotechnology Conservation Processes: Similarities with Natural Long-Term Preservation of Biological Organisms.
A. Laurent et al. (31 janv. 2023)
Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects.
A. Laurent et al. (10 janv. 2023)
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care.
A. Laurent et al. (4 janv. 2023)
Grands défects chondraux et ostéochondraux du genou : traitement par greffe chondrocytaire autologue [Treatment of extensive chondral and osteochondral knee defects with autologous chondrocytes implantation]
R. Martin et al. (14 déc. 2022)
Filamented Light (FLight) Biofabrication of Highly Aligned Tissue-Engineered Constructs.
H. Liu et al.
Exudative glutamine losses contribute to high needs after burn injury.
M.M. Berger et al.
Retrospective Analysis of Autologous Chondrocyte-Based Cytotherapy Production for Clinical Use: GMP Process-Based Manufacturing Optimization in a Swiss University Hospital.
V. Philippe et al. (17 mars 2022)
Synergistic effects of antimicrobial peptide dendrimer-chitosan polymer conjugates against Pseudomonas aeruginosa.
V. Patrulea et al. (15 mars 2022)
Combination of Hyaluronan and Lyophilized Progenitor Cell Derivatives: Stabilization of Functional Hydrogel Products for Therapeutic Management of Tendinous Tissue Disorders.
A. Laurent et al. (19 déc. 2021)
Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland.
A. Laurent et al. (17 déc. 2021)
Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine.
A. Jeannerat et al. (25 oct. 2021)
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
M. Chemali et al. (30 sept. 2021)
Corrigendum to: Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
M. Chemali et al. (30 sept. 2021)
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine.
A. Laurent et al. (23 août 2021)
Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.
A. Grognuz et al. (3 avr. 2021)
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.
L. Deghayli et al. (28 févr. 2021)
Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation.
A. Laurent et al. (9 févr. 2021)

next